Press release
Future and Scope of Bio-Engineered Protein Drugs Market by 2020
Request to view Sample Report @ http://www.persistencemarketresearch.com/samples/3295
The global bioengineered protein drugs market is categorized into monoclonal antibodies, cytokines, peptide hormones, vaccines, therapeutic enzymes and blood products. The cytokines segment includes interferon, interleukins and colony stimulating factors. The peptide hormone segment is sub-divided into insulin, growth hormones and erythropoietin. Vaccines include toxoid, live attenuated vaccines and killed vaccines. The therapeutic enzyme segment is further sub-segmented into digestive and metabolic enzymes. Blood products include thrombin, alpha 1-Protease inhibitor and coagulation factors.
In terms of geographic, North America and Europe dominates the global bio-engineered protein drugs market due to improved biopharmaceutical industry in the region. The U.S. represents the largest market for bio-engineered protein drugs followed by Canada in North America. In Europe, France and Germany holds major share of bio-engineered protein drugs market. However, Asia is expected to show high growth rates in the next five years in global bio-engineered protein drugs market due to improving life science research infrastructure in the region. Japan, China and India are expected to be the fastest growing bio-engineered protein drugs market in Asia.
In recent time, increasing prevalence of chronic diseases, such as cancer, diabetes and asthma is key driver for the global bio-engineered protein drugs market. For instance, according to the International Agency for Research on Cancer (IARC), a specialized agency of the WHO, an estimated 12.7 million new cancer cases were reported in 2008 and the number reached 14.1 million in 2012. This increasing prevalence of chronic diseases has resulted in significant rise in demand of bio-engineered protein drugs for their treatment. In addition, advancement in manufacturing technologies is also supporting in growth of the global bio-engineered protein drugs market. However, high cost of protein drugs is key restraint for the global bio-engineered protein drugs market. Moreover, complications associated with the treatment of diseases by protein drugs also obstruct the growth of global bio-engineered protein drugs market.
Request to view Table of content @ http://www.persistencemarketresearch.com/toc/3295
Some of the major companies operating in the global bio-engineered protein drugs market are Abbott Laboratories, Allergan, Baxter International, Bayer HealthCare, Sanofi, Pfizer Inc., Johnson & Johnson, Novartis, Merck and Glaxosmithkline.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future and Scope of Bio-Engineered Protein Drugs Market by 2020 here
News-ID: 399534 • Views: …
More Releases from Persistence Market Research Pvt. Ltd
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size
The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032.
The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation…
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers
The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism.
Stay Ahead with Market Intelligence Get Free…
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.
Market Overview
The biosimulation market has experienced rapid growth…
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market
The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961
The global wheelchair and components market has witnessed significant growth in…
More Releases for Proteins
Plant Proteins Market Growth, Trends, and Forecast 2025 | Demand for Vegan & Pla …
The latest report published by DataM Intelligence highlights the growth prospects of Plant Proteins market. The industry expansion is majorly driven by developments in technology across the globe.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/plant-proteins-market?sz
The Global Plant Protein Market reached US$ 17 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 34 billion by 2031. The…
Difficult-to-Express Proteins Market: Shift Towards Protein Therapeutics and Rec …
The Projections for the Rapidly Expanding Difficult-to-Express Proteins Market Size
• The difficult-to-express proteins market size has shown considerable growth, with the market size projected to increase from $4.65 billion in 2024 to $5.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.1%. This expansion is strongly influenced by the increased demand for protein therapeutics, technological advancements in biopharmaceuticals, and challenges in drug development.
• Looking ahead, the…
Functional Proteins Market To Show Strong Growth & Demand | AMCO Proteins, Milk …
The ' Functional Proteins market' research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Functional Proteins market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Functional Proteins market size forecast, market…
FutureBridge: Research reveals four next-generation proteins best-positioned to …
There is a need for manufacturers to start looking beyond wheat, soy and pea to allow for a more diverse palate of crops to work with - says FutureBridge
Utrecht, The Netherlands, April 21, 2020: Consumer demand for a healthier and more sustainable diet continues to drive new plant protein products onto retail shelves. The global plant-based protein market will reach $10.8B by 2022, supported by a CAGR of 6.7%.
But growing…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…
Antifreeze Proteins Market
Global Antifreeze Proteins Market to reach USD 16.27 million by 2025.
Global Antifreeze Proteins Market valued approximately USD 1.44 million in 2016 is forecasted to grow with a healthy growth rate of more than 30.92% over the forecast period 2018-2025. The major factors speculated to augment the markets are improvements in technology to augment fish farming in cooler climates, and benefits associated with antifreeze proteins. evolving markets, and growing investments in…
